P. K. Patra, H.-U. Reißig
FULL PAPER
H, NCH2, 6-H), 1.93 (d, J ϭ 5.8 Hz, 1 H, 4-H), 1.64 (br. s, 1 H, 2.39Ϫ2.30 (4 m, 2 H, 6 H, 12 H, 2 H, CH2, CH). Ϫ 13C NMR
NH), 1.27 (d, J ϭ 5.8 Hz, 1 H, 4-H), 0.89 (s, 9 H, tBu), 0.13, 0.11 (75.5 MHz, CDCl3): δ ϭ 210.6 (s, CϭO), 175.0, 51.9 (s, q, CO2Me),
(2 s, 6 H, SiMe2). Ϫ 13C NMR (62.9 MHz, CDCl3): δ ϭ 172.1,
138.5 (s, Ph), 130.2, 130.0, 129.4, 129.0, 127.1 (5 d, Ph, C-3, C-4,
51.8 (s, q, CO2Me), 159.4, 159.2 (2 s, C-pyr), 140.2, 139.5 (2 s, Ph), C-13, C-14), 58.5 (t, CH2Ph), 50.0, 48.4, 42.7 (3 t, C-2, C-5, C-10,
136.8, 136.3 (2 d, C-2, C-pyr), 131.5, 129.5, 128.7, 128.3, 128.1,
126.8, 126.7 (7 d, ϭCH, Ph), 120.3, 119.9 (2 d, C-pyr), 115.1 (t, C-
1), 65.3 (s, C-3), 59.6, 57.9, 55.5, 53.2, 50.7 (5 t, NCH2), 37.1 (s, C-
5), 36.8 (t, C-6), 25.8, 18.1 (q, s, tBu), 24.4 (t, C-4), Ϫ3.5 (q, SiMe2).
Ϫ MS (EI, 80 eV): m/z (%) ϭ 625 (22) [Mϩ], 361 (100). Ϫ HRMS:
C-12, C-15, C-20), 38.8 (d, C-16, C-6), 37.9 (t, C-7, C-17), 26.9 (t,
C-9, C-19). Ϫ MS (FAB): m/z (%) ϭ 603 [Mϩ ϩ 1] (4), 91 (100).
Methyl (3E,8E)-1,6-Dibenzyl-13-oxo-1,6-diazacyclopentadeca-3,8-
diene-11-carboxylate (21): According to general procedure C, di-
amine 6 (456 mg, 0.79 mmol) was cyclized in the presence of CsF
(362 mg, 2.38 mmol) and TEBA (270 mg, 1.19 mmol) in dry DMF
(450 mL) for 24 h, followed by workup and column chromato-
graphy using silica gel (EtOAc/hexane, 4:6) to yield 21 (110 mg,
calcd. for C38H51N3O3Si: 625.36997; found 625.36933.
Ϫ
C38H51N3O3Si (625.9): calcd. C 72.91, H 8.21, N 6.71; found C
72.66, H 7.97, N 6.76.
Synthesis of Amine 18: Following general procedure A, cyclopropyl
bromide 17 (740 mg, 1.18 mmol) was treated with benzylamine (ϭCϪH, CϪH), 1735 (CO2Me), 1715 (CϭO), 1640 (CϭC). Ϫ H
31%) as a colourless liquid. Ϫ IR (film): ν˜ ϭ 3085Ϫ2800 cmϪ1
1
(1.27 g, 11.8 mmol) in dichloromethane (25 mL). Workup and puri-
fication by column chromatography (silica gel, hexane/EtOAc, 1:4)
NMR (250 MHz, CDCl3): δ ϭ 7.40Ϫ7.22 (m, 10 H, Ph), 5.67 (mc,
2 H, 3-H, 4-H), 5.52 (mc, 2 H, 8-H, 9-H), 3.70 (s, 3 H, CO2Me),
afforded 18 (590 mg, 78%) as a light yellow liquid. Ϫ IR (film): 3.63Ϫ3.49 (m, 4 H, 2 CH2Ph), 3.20Ϫ2.41, 2.27Ϫ2.13 (2 m, 14 H,
Ϫ1
(NϪH), 3060Ϫ2860 (ϭCϪH, CϪH), 1735 1 H, CH2, CH). Ϫ 13C NMR (62.9 MHz, CDCl3): δ ϭ 209.0 (s,
˜
ν ϭ 3325 cm
(CO2Me), 1640, 1590 (CϭC). Ϫ 1H NMR (250 MHz, CDCl3): δ ϭ CϭO), 175.3, 51.9 (s, q, CO2Me), 139.4, 138.9, 128.9, 128.8, 128.7,
7.49 (t, J ϭ 7.7 Hz, 1 H, pyr-H), 7.39Ϫ7.21 (m, 5 H, Ph), 7.03 (d, 128.2 (2 s, 4 d, Ph), 131.6, 130.9 (2 d, C-3, C-4), 127.0, 126.9 (2 d,
J ϭ 7.7 Hz, 1 H, pyr-H), 6.93 (d, J ϭ 7.7 Hz, 1 H, pyr-H), 5.79 C-8, C-9), 60.2 (t, C-2), 58.7 (t, C-5), 55.5, 55.4, 55.4 (3 t, 2 CH2Ph,
(dd, J ϭ 16.7, 10.3 Hz, 1 H, 2-H), 5.30 (mc, 2 H, 7-H, 8-H), 5.24 C-7), 48.9 (t, C-15), 42.3, 41.1 (2 t, C-10, C-12), 39.2 (d, C-11), 34.0
(dd, J ϭ 16.7, 1.0 Hz, 1 H, 1-H), 5.08 (dd, J ϭ 10.3, 1.0 Hz, 1 H, (t, C-14). Ϫ MS (EI, 80 eV): m/z (%) ϭ 460 (14) [Mϩ], 429 [Mϩ Ϫ
1-H), 3.77 (s, 4 H, NCH2), 3.64, 3.63 (2 s, 9 H, 3 CO2Me), 3.36 (s,
2 H, 11-H), 2.81 (br. dd, J ϭ 17.2, 4.4 Hz, 1 H, 6-H), 2.48 (mc, 2 460.27259; found 460.27058. Ϫ C29H36N2O3 (460.6): calcd. C
31] (18), 369 [Mϩ Ϫ 91] (100). Ϫ HRMS: calcd. for C29H36N2O3:
H, 9-H), 2.16 (br. s, 1 H, NH), 2.15 (br. dd, J ϭ 17.2, 4.4 Hz, 1 H,
6-H), 1.80 (d, J ϭ 5.8 Hz, 1 H, 4-H), 0.97 (d, J ϭ 5.8 Hz, 1 H, 4-
H), 0.90 (s, 9 H, tBu), 0.10, 0.08 (2 s, 6 H, SiMe2). Ϫ 13C NMR
(62.9 MHz, CDCl3): δ ϭ 171.9, 171.4, 52.3, 51.9 (2 s, 2 q, CO2Me),
158.9, 156.4 (2 s, C-pyr), 140.0, 128.3, 128.3, 126.8 (s, 3 d, Ph),
136.7, 136.4 (2 d, C-pyr, C-2), 132.2 (d, C-7), 125.4 (d, C-8), 122.3,
120.0 (2 d, C-pyr), 115.2 (t, C-1), 65.1 (s, C-3), 57.5 (s, C-10), 54.3,
53.5 (2 t, NCH2), 39.3 (t, C-11), 37.5 (s, C-5), 35.3, 31.8 (2 t, C-6,
C-9), 25.8, 18.2 (q, s, tBu), 13.6 (t, C-4), Ϫ3.4, Ϫ3.6 (2 q, SiMe2).
Ϫ MS (EI, 80 eV): m/z (%) ϭ 650 (32) [Mϩ], 619 [Mϩ Ϫ 31] (26),
559 [Mϩ Ϫ 91] (21), 237 (100). Ϫ HRMS: calcd. for C36H50N2O7:
650.33873; found 650.33809.
75.62, H 7.87, N 6.08; found C 73.90, H 7.48, N 5.62.
Trimethyl (3E,8E)-1-Benzyl-13-oxo-1-azacyclopentadeca-3,8-diene-
6,6,11-tricarboxylate (22): Following general procedure C, amine 8
(1.25 g, 2.08 mmol) was cyclized in the presence of CsF (951 mg,
6.26 mmol) and TEBA (712 mg, 3.12 mmol) in dry DMF (750 mL)
for 25 h, followed by workup and column chromatography using
silica gel (EtOAc/hexane, 1:9) to yield 22 (191 mg, 19%) as a col-
Ϫ1
˜
ourless liquid. Ϫ IR (film): ν ϭ 3165Ϫ2610 cm (ϭCϪH, CϪH),
1
1705 (CO2Me), 1680 (CϭC). Ϫ H NMR (500 MHz, CDCl3): δ ϭ
7.28Ϫ7.24 (m, 2 H, Ph), 7.21Ϫ7.18 (m, 3 H, Ph), 5.59Ϫ5.54 (m, 1
H, 3-H), 5.42Ϫ5.36 (m, 1 H, 9-H), 5.29 (mc, 2 H, 8-H, 4-H), 3.66,
3.64 (2 s, 9 H, 3 CO2Me), 3.56, 3.45 (AB system, JAB ϭ 14.0 Hz,
2 H, CH2Ph), 2.95Ϫ2.78, 2.68Ϫ2.41, 2.19Ϫ2.13 (3 m, 6 H, 8 H, 1
H, CH2, CH). Ϫ 13C NMR (125 MHz, CDCl3): δ ϭ 208.7 (s,
Methyl
(E)-1-Benzyl-4-oxo-1,2,3,4,5,6,7,10-octahydroazecine-6-
carboxylate (19): Following general procedure C, amine 3 (300 mg,
0.72 mmol) in DMF (50 mL) was treated with a warm suspension CϭO), 175.0, 171.4, 171.0, 52.5, 52.3, 51.8 (3 s, 3 q, CO2Me), 138.7,
of CsF (330 mg, 2.17 mmol) and TEBA (247 mg, 1.08 mmol) in 131.0, 128.6, 128.2 (s, 3 d, Ph), 132.0 (d, C-3), 126.9, 126.6, 125.5
DMF (250 mL) for 22 h. Workup and purification by silica gel col-
umn chromatography (EtOAc/hexane, 1:9) afforded 19 (50 mg,
24%) as a thick, colourless liquid, along with dimer 20 (4 mg, 4%,
colourless liquid, one diastereomer) as the second fraction. Ϫ IR
(3 d, C-9, C-4, C-8), 60.3 (s, C-6), 58.6, 55.8 (2 t, CH2Ph, C-2),
49.5 (t, C-15), 41.9, 41.5 (2 t, C-5, C-7), 39.3 (d, C-11), 35.2, 35.1
(2 t, C-12, C-10), 33.7 (t, C-14). Ϫ MS (EI, 80 eV): m/z (%) ϭ 485
(7) [Mϩ], 454 [Mϩ Ϫ 31] (18), 394 [Mϩ Ϫ 91] (59), 106 (100). Ϫ
(film): ν˜ ϭ 3085Ϫ2910 cmϪ1 (ϭC-H, CϪH), 1735 (CO2Me), 1705 HRMS: calcd. for C27H35NO7: 485.24135; found 485.24069.
(CϭO), 1640 (CϭC). Ϫ 1H NMR (300 MHz, CDCl3): δ ϭ
Trimethyl (3E,8E,13E)-1,6-Dibenzyl-18-oxo-1,6-diazacycloeicosa-
7.32Ϫ7.23 (m, 5 H, Ph), 5.59 (mc, 1 H, 8-H), 5.25 (mc, 1 H, 9-H),
3,8,13-triene-11,11,16-tricarboxylate (23): Following general pro-
3.69 (s, 3 H, CO2Me), 3.65 (s, 2 H, CH2Ph), 3.45Ϫ3.34 (m, 2 H,
cedure C, diamine 10 (495 mg, 0.65 mmol) was cyclized in the pres-
10-H), 2.94Ϫ2.52 (m, 7 H, CH, CH2), 2.47Ϫ2.26, 2.06Ϫ1.94 (2 m,
ence of CsF (297 mg, 1.95 mmol) and TEBA (223 mg, 0.98 mmol)
in dry DMF (450 mL) for 25 h, followed by workup and column
1 H each, CH2). Ϫ 13C NMR (75.5 MHz, CDCl3): δ ϭ 208.8 (s,
CϭO), 174.6, 51.9 (s, q, CO2Me), 138.0, 128.8, 128.3, 127.1 (s, 3 d,
chromatography using silica gel (EtOAc/hexane, 3:7) to yield 23
Ph), 134.4, 130.2 (2 d, C-9, C-8), 62.2, 58.9 (2 t, CH2Ph, C-10),
˜
(258 mg, 62%) as a colourless liquid. Ϫ IR (film): ν ϭ 3060Ϫ2800
50.0, 45.3, 45.0 (3 t, C-2, C-5, C-3), 44.8 (d, C-6), 36.5 (t, C-7). Ϫ
MS (EI, 70 eV): m/z (%) ϭ 301 (14) [Mϩ], 210 [Mϩ Ϫ CH2Ph] (46),
91 (100). Ϫ C18H23NO3 (301.4): calcd. C 71.73, H 7.69, N 4.65;
found C 71.48, H 7.48, N 4.71.
cmϪ1 (ϭCϪH, CϪH), 1735 (CO2Me), 1640 (CϭC). Ϫ 1H NMR
(250 MHz, CDCl3): δ ϭ 7.32 (mc, 10 H, 2 Ph), 5.74 (mc, 2 H,
ϭCH), 5.68Ϫ5.19 (m, 4 H, ϭCH), 3.71, 3.68 (2 s, 9 H, 3 CO2Me),
3.57 (mc, 4 H, 2 CH2Ph), 3.20Ϫ2.78, 2.66Ϫ2.52, 2.49Ϫ2.22 (3 m,
10 H, 6 H, 3 H, CH2, CH). Ϫ 13C NMR (62.9 MHz, CDCl3): δ ϭ
Dimethyl (3E,13E)-1,11-Dibenzyl-8,18-dioxo-1,11-diazacycloeicosa-
3,13-diene-6,16-dicarboxylate (20): 1H NMR (300 MHz, CDCl3): 208.3 (s, CϭO), 174.7, 171.2, 171.1, 52.5, 51.9 (3 s, 2 q, CO2Me),
δ ϭ 7.35Ϫ7.24 (m, 10 H, Ph), 5.63 (mc, 2 H, 3-H, 13-H), 5.50 (mc,
139.2, 138.8 (2 s, Ph), 132.1, 130.8, 130.7, 128.9, 128.7, 128.2, 127.8,
2 H, 4-H, 14-H), 3.79, 3.41 (AB system, JAB ϭ 13.0 Hz, 2 H each, 127.6, 127.0, 126.9, 126.8 (11 d, Ph, ϭCH), 58.7, 58.7, 55.5, 54.9,
CH2Ph), 3.72 (s, 6 H, CO2Me), 3.36Ϫ3.26, 3.14Ϫ3.02, 2.86Ϫ2.44, 54.5 (5 t, 2 CH2Ph, 3 CH2), 57.0 (s, C-11), 48.8, 42.1, 41.0 (3 t, 3
4202
Eur. J. Org. Chem. 2001, 4195Ϫ4206